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Abstract
Many disciplines, from human genetics and oncology to plant breeding, microbiology and virology, commonly face the chal-
lenge of analyzing rapidly increasing numbers of genomes. In case of Homo sapiens, the number of sequenced genomes will
approach hundreds of thousands in the next few years. Simply scaling up established bioinformatics pipelines will not be
sufficient for leveraging the full potential of such rich genomic data sets. Instead, novel, qualitatively different computa-
tional methods and paradigms are needed. We will witness the rapid extension of computational pan-genomics, a new
sub-area of research in computational biology. In this article, we generalize existing definitions and understand a pan-
genome as any collection of genomic sequences to be analyzed jointly or to be used as a reference. We examine already
available approaches to construct and use pan-genomes, discuss the potential benefits of future technologies andmethod-
ologies and review open challenges from the vantage point of the above-mentioned biological disciplines. As a prominent
example for a computational paradigm shift, we particularly highlight the transition from the representation of reference
genomes as strings to representations as graphs. We outline how this and other challenges from different application do-
mains translate into common computational problems, point out relevant bioinformatics techniques and identify open
problems in computer science. With this review, we aim to increase awareness that a joint approach to computational pan-
genomics can help address many of the problems currently faced in various domains.
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Introduction
In 1995, the complete genome sequence for the bacterium
Haemophilus influenzae was published [1], followed by the se-
quence for the eukaryote Saccharomyces cerevisiae in 1996 [2] and
the landmark publication of the human genome in 2001 [3, 4].
These sequences, and many more that followed, have served as
‘reference genomes’, which formed the basis for both major ad-
vances in functional genomics and for studying genetic vari-
ation by re-sequencing other individuals from the same species
[5–8]. The advent of rapid and cheap ‘next-generation’ sequenc-
ing technologies since 2006 has turned re-sequencing into one
of the most popular modern genome analysis workflows. As of
today, an incredible wealth of genomic variation within popula-
tions has already been detected, permitting functional annota-
tion of many such variants, and it is reasonable to expect that
this is only the beginning.
With the number of sequenced genomes steadily increasing,
it makes sense to re-think the idea of a ‘reference’ genome
[9, 10]. Such a reference sequence can take a number of forms,
including:
• the genome of a single selected individual,
• a consensus drawn from an entire population,
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• a ‘functional’ genome (without disabling mutations in any genes)
or
• a maximal genome that captures all sequence ever detected.
Depending on the context, each of these alternatives may
make sense. However, many early reference sequences did not
represent any of the above. Instead, they consisted of collec-
tions of sequence patches, assayed fromwhatever experimental
material had been available, often from a relatively unstruc-
tured mix of individual biological sources. Only lately has the
rapid spread of advanced sequencing technologies allowed the
reasonably complete determination of many individual genome
sequences from particular populations [7], taxonomic units [11]
or environments [12]. To take full advantage of these data, a
good ‘reference genome’ should have capabilities beyond the al-
ternatives listed above. This entails a paradigm shift, from
focusing on a single reference genome to using a ‘pan-genome’,
that is, a representation of all genomic content in a certain spe-
cies or phylogenetic clade.
Definition of computational pan-genomics
The term ‘pan-genome’ was first used by Sigaux [13] to describe
a public database containing an assessment of genome and
transcriptome alterations in major types of tumors, tissues and
experimental models. Later, Tettelin et al. [9] defined a microbial
pan-genome as the combination of a ‘core’ genome, containing
genes present in all strains, and a ‘dispensable’ genome (also
known as flexible or accessory genome) composed of genes ab-
sent from one or more of the strains. A generalization of such a
representation could contain not only the genes, but also other
variations present in the collection of genomes. The idea of tran-
sitioning to a human pan-genome is also gaining attention (see
http://www.technologyreview.com/news/537916/rebooting-the-
human-genome, for an example of recent media coverage).
While the pan-genome is thus an established concept, its (com-
putational) analysis is frequently still done in an ad hocmanner.
Here, we generalize the above definitions and use the term
‘pan-genome’ to refer to any collection of genomic sequences to
be analyzed jointly or to be used as a reference. These se-
quences can be linked in a graph-like structure, or simply con-
stitute sets of (aligned or unaligned) sequences. Questions
about efficient data structures, algorithms and statistical meth-
ods to perform bioinformatic analyses of pan-genomes give rise
to the discipline of ‘computational pan-genomics’.
Our definition of a pan-genome allows capturing a diverse set
of applications across different disciplines. Examples include
‘classical’ pan-genomes consisting of sets of genes present in a
species [14], graph-based data structures used as references to
enhance the analysis of difficult genomic regions such as the
major histocompatibility complex (MHC) [15], the compact repre-
sentation of a transcriptome [16] and the collection of virus
haplotypes found in a single patient [17].
While being aware that the above definition of a pan-
genome is general, we argue that it is instrumental for identify-
ing common computational problems that occur in different
disciplines. Our notion of computational pan-genomics there-
fore intentionally intersects with many other bioinformatics
disciplines. In particular it is related to ‘metagenomics’, which
studies the entirety of genetic material sampled from an envir-
onment; to ‘comparative genomics’, which is concerned with
retracing evolution by analyzing genome sequences; and to
‘population genetics’, whose main subject is the change of a
population’s genetic composition in response to various evolu-
tionary forces and migration. While none of these fields cap-
tures all aspects of pan-genomics, they all have developed their
own algorithms and data structures to represent sets of gen-
omes and can therefore contribute to the pan-genomics tool-
box. By advocating ‘computational pan-genomics’, we hope to
increase awareness of common challenges and to generate syn-
ergy among the involved fields.
At the core of pan-genomics is the idea of replacing trad-
itional, linear reference genomes by richer data structures. The
paradigm of a single reference genome has endured in part be-
cause of its simplicity. It has provided an easy framework
within which to organize and think about genomic data; for ex-
ample, it can be visualized as nothing more than linear text,
which has allowed the development of rich two-dimensional
genome browsers [18, 19]. With the currently rapidly growing
number of sequences we have at our disposal, this approach in-
creasingly fails to fully capture the information on variation,
similarity, frequency and functional content implicit in the
data. Although pan-genomes promise to be able to represent
this information, there is not yet a conceptual framework or a
toolset for working with pan-genomes that has achieved wide-
spread acceptance. For many biological questions, it is not yet
established how to best extract the relevant information from
any particular pan-genome representation, and even when the
right approach can be identified, novel bioinformatics tools
often need to be developed to apply it.
In this article, we explore the challenges of working with
pan-genomes, and identify conceptual and technical
approaches that may allow us to organize such data to facilitate
their application in (green, blue, red and white [20]) biotechnol-
ogy and fundamental research.
Goals of computational pan-genomics
On a high level, desirable features of a pan-genome include
‘completeness’, or containing all functional elements and
enough of the sequence space to serve as a reference for the
analysis of additional individuals; ‘stability’, or having uniquely
identifiable features that can be studied by different researchers
and at different points in time; ‘comprehensibility’, or facilitat-
ing understanding of the complexities of genome structures
across many individuals or species; and ‘efficiency’, or organiz-
ing data in such a way as to accelerate downstream analysis.
These desiderata highlight the breadth of challenges facing
pan-genomics as a field, some of which go beyond scientific
questions. Reaching ‘completeness’, for instance, requires the
necessary (financial and technical) resources to collect and se-
quence a sufficient number of genomes for a particular tissue,
organism, species, other taxonomic unit, ecological community
or geospatial niche of interest to be accurately represented. The
availability of data sharing mechanisms will greatly influence
how quickly ‘completeness’ can be achieved. Issues of data
sharing include technical ones (mostly owing to the data being
big), political ones and ethical/privacy concerns [21], as well as
issues related to the interplay of these three areas. Achieving
‘stability’ requires a central, recognized authority equipped with
the long-term resources for curating reference pan-genomes.
Besides this organizational component, achieving stability also
requires reaching consensus about ways to define coordinate
systems on pan-genomes. The goal of ‘comprehensibility’ is
mostly a biological problem. What it means exactly can differ
substantially between application domains. The goal of
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‘efficiency’, on the other hand, is in the domain of computer sci-
ence. Aligning the needs of researchers in the application do-
mains with efforts to develop algorithms and statistical
methods is key to designing efficient solutions. With this article,
we hope to contribute significantly to this communication
process.
Applications
Pan-genomes arise in many different application domains. In
this section, we discuss seven different fields: Microbes,
Metagenomics, Viruses, Plants, Human Genetic Diseases,
Cancer and Phylogenomics. While this list of areas related to
pan-genomics is not exhaustive, we aimed to select those that
we believe are most strongly impacted by novel pan-genomics
methods, and hence are most relevant to our goal of identifying
common computational challenges.
Microbes
Bacteria and fungi are widely studied—and applied—in fields
including biology, medicine and biotechnology. A full under-
standing of the functional and evolutionary repertoire of micro-
bial genomes thus not only is interesting from a scientific point
of view, but also opens up possibilities for developing therapies
and engineering applications.
For a number of microorganisms, pan-genome sequence
data are already available; refer to [22, 23] for examples.
Microbes provide a unique opportunity for pan-genome
construction: the size of their genomes is relatively small, and
for many species, there are multiple fully closed genome se-
quences available. Furthermore, for some clinically interesting
bacterial species, up to thousands of sequenced strains are
available at sufficient depth to create draft genome assemblies.
This has enabled pan-genome studies at the gene level [14],
for which established workflows and mature software are
available, as reviewed in [24]. With the current data, however,
we are in a position to create a pan-genome at the sequence
level, as in e.g. [25]. In this context, a pan-genome is a represen-
tation that encodes the complete sequence information of
many individual strains.
From an evolutionary point of view, microbial pan-genomes
support comparative genomics studies. These are particularly
interesting owing to most microorganisms’ potential for hori-
zontal gene exchange. This means that not all genes in a gen-
ome adhere to the same phylogenetic sub-tree [26]. Thus, the
evolution of microorganisms including bacteria, but also higher
organisms [27], is more naturally represented as a phylogenetic
network, rather than a phylogenetic tree [28]. We envision that
these phylogenetic networks can be encoded in the structure of
the pan-genome.
Applying genome-wide association studies (GWAS) to mi-
crobes is an emerging field [29, 30], promising to pinpoint gen-
etic variables that correlate with relevant traits such as drug
resistance or secondary metabolism. Such studies can operate
at the level of individual variants—such as single-nucleotide
polymorphisms (SNPs), insertion/deletion variants (indels) and
structural variants (SVs)—or at the level of absence or presence
of whole genes, annotated functions or mobile genetic elements
such as integrons or prophages. Computational pan-genomic
approaches could be applied at each of these levels. Important
challenges amenable to a pan-genomic approach include estab-
lishing reliable data processing pipelines to deliver variant calls,
extracting gene absence/presence signals from next-generation
sequencing (NGS) data, annotation for hypothetical genes and
proteins and specifically computational challenges such as the
definition of a coordinate system to identify sequence loci on
pan-genomes or the handling nested variation, such as SNP
positions in large insertions. By addressing these challenges,
computational pan-genomics has the potential to substantially
contribute to the success of microbial GWAS.
Metagenomics
Metagenomics studies the genomic composition of microorgan-
isms sampled from an environment. Abundant metagenomic
data are currently being generated from various environments
such as human hosts [12, 31], the world’s oceans [32, 33] and
soil [34]. One main advantage of this approach lies in allowing
the sampling of ‘all’ microorganisms in an environment, not
only those that can be cultured. This however comes at the cost
of having to untangle the sequencing data generated from such
a mixture computationally. A first question often asked is about
the taxonomic composition of the sample. Other relevant ques-
tions that can be approached with metagenomic data include
ascertaining the presence of certain gene products or whole
pathways, and determining which genomes these functional
genes are associated with.
Metagenomics can be applied to gain insights on human
health and disease. Metagenome-wide association studies that
aim to associate the microbial composition in the human gut
with diseases such as type 2 diabetes are an example [35].
Metagenomics has also been shown to be capable of revealing
the genomes of entire species, and tracing them through envir-
onments, as in the example of the shiga-toxigenic Escherichia coli
being responsible for a recentmajor outbreak in Germany [36].
In the metagenomic setting, the set of genomic sequences
underlying a pan-genome is not defined by ancestral relation-
ships, but by co-occurrence in an environment. This presents
both a challenge and an opportunity. On the one hand, con-
structing such a pan-genome and drawing robust conclusions
from it are difficult, especially when sequencing reads are short.
On the other hand, it presents the chance to reveal common
adaptations to the environment as well as co-evolution of
interactions.
Viruses
Viruses are notorious mutation machines. A viral quasi-species
is a cloud of viral haplotypes that surround a given master virus
[17]. Although viral genomes are comparatively short (RNA
viruses range from 3 to 30 kb, DNA viruses are usually not larger
than 3 Mb), their high sequence variability makes it challenging
to assemble full viral genomes de novo. There are two major
sequencing approaches for viruses: sequencing isolated viral
clones, and metagenomic sequencing. The latter usually identi-
fies a metapopulation consensus genome sequence rather than
a single haplotype [37], and includes confounding genetic se-
quences such as the genome of other community members and
of the cellular virus host. Thus far, the obvious approach of viral
particle sorting by Fluorescence-Activated Cell Sorting, followed
by single virus sequencing, has remained elusive owing to
their small genome size [38, 39]. New long-read technologies
(e.g. PacBio, Oxford Nanopore) are now providing the first prom-
ising results in the sequencing of complete viral genomes [40,
41]. Currently, error rates in these third-generation long read
sequencing technologies still far exceed the frequencies of rare
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strains or haplotypes. However, as sequencing chemistry and
technologies progress, such techniques are likely to become key
tools for the construction of viral pan-genomes.
Low-frequency strains are hardly detectable, especially for
fast-evolving RNA viruses with a replication mutation rate simi-
lar to sequencing error rates. Reliable viral haplotype recon-
struction is not fully solved, although to date many promising
approaches have been presented [42]. Haplotype resolution
techniques such as Strand-Seq [43] are not applicable for small
virus particles.
One of the goals of pan-genomics, both in virology and in
medical microbiology, will be to fight infectious disease. We ex-
pect that computational pan-genomics will assist GWAS
approaches, which may allow the prediction of crucial param-
eters such as the exact diagnosis, staging and suitable therapy
selection from a given patient’s viral pan-genome. For example,
several studies have shown relationships between genetic di-
versity and disease progression, pathogenesis, immune escape,
effective vaccine design and drug resistance in HIV [44–46].
Thus, computational pan-genomics promises to be useful when
studying the response of the quasi-species to the host immune
system, in the context of personalized medicine.
The molecular interactions between pathogens and their
hosts lead to a genetic arms race that allows virus–host inter-
actions to be predicted [47]. In this context, metagenomics
techniques can also be applied [48, 49]. The large metagenomic
data sets mentioned in the ‘Metagenomics’ section can serve
as input for such studies. We expect that computational pan-
genomics will allow increased power and accuracy, for
example by allowing the pan-genome structure of a viral
population to be directly compared with that of a susceptible
host population.
Plants
Genomic hybridization of accessions of crops or flowers has
been exploited for over a century to create offspring with desir-
able traits. Genes found in wild varieties that improve import-
ant properties of crops, such as appearance, nutrient content,
resistance to certain pests or diseases or tolerance for stresses
such as drought or heat, are now routinely bred into commer-
cial crop varieties.
Large-scale genomics projects to characterize the genetic di-
versity in plants are already ongoing, not only for the model
plant Arabidopsis thaliana [5], but also for crops [50]. Examples in-
clude the re-sequencing of hundreds to thousands of varieties
of rice [51], maize [52], sorghum [53] and tomato [6]. Future pro-
jects aim to sequence many more varieties, e.g. 100,000 varieties
of rice (http://irri.org/our-work/research). Mining and leveraging
the sequence data in such large-scale projects require a pan-
genomic approach. Particularly challenging is the fact that
many plant genomes are large, complex (containing many re-
peats) and often polyploid.
A pan-genome structure has multiple advantages over a sin-
gle, linear reference genome sequence in plant breeding appli-
cations. Having a pan-genome available for a given crop that
includes its wild relatives provides a single coordinate system
to anchor all known variation and phenotype information, and
will allow for identification of novel genes from the available
germplasm that are not present in the reference genome(s).
Moreover, the pan-genome will reveal chromosomal rearrange-
ments between genotypes, which can hinder the introgression
of desired genes. It also provides a compact representation of
polyploid genomes and, in case of autopolyploids, allows for the
quantitation of allele dosage between individuals.
Human genetic diseases
A key objective in human genetics is to develop a full under-
standing of how genotype influences phenotype. To date, nu-
merous genes have been successfully mapped for rare
monogenic diseases, where a rare mutation results, in most
cases, in disease. For mutations with (almost) fully penetrant
effects, linkage analysis in affected pedigrees has demon-
strated to be a highly effective approach for localizing causal
genes, with a few thousand of such disease genes now anno-
tated in the Online Mendelian Inheritance in Man (http://
omim.org/). More recently, whole-exome sequencing in fami-
lies offered a complimentary and perhaps more efficient ap-
proach, pinpointing culprit mutations in novel disease genes
and in specific cases revealing a role for de novo mutations in
affected offspring (without familial segregation). By comparing
observed variants in affected family members to those present
in the population at large [e.g. the Exome Variant Server (http://
evs.gs.washington.edu/EVS) and the ExAC Browser (http://
exac.broadinstitute.org)] [54], it is possible to implicate such
variants as being pathogenic on the basis of their frequency in
the population. Yet, caution is warranted because any genome
sequence may contain many potentially functional, rare vari-
ants that could result in false-positive claims about disease-
causing variants [55].
Historically, common diseases have been more challenging
to study because they arise from the interplay of many genetic
and nongenetic risk factors, each of which only contribute mod-
estly to the overall risk. Thanks to systematic approaches to in-
terrogate human genomic variation in large numbers, GWAS
have identified thousands of robust genotype–phenotype asso-
ciations for a wide range of human traits and diseases. Critical
to this success have been catalogs of human genome variation,
their linkage disequilibrium (LD) properties as well as the com-
mercial development of cheap microarrays. One of the primary
applications of the resources provided by the HapMap [56] and
1000 Genomes [8] (1KG) projects was LD-based imputation [57],
allowing GWAS to test many more variants than typically pre-
sent on a single microarray chip.
Although the 1KG database is predicted to include >99% of
all variants with a frequency of at least 1% [8], many other inde-
pendent sequencing efforts revealed that many variants below
1% remain to be discovered as we continue to sequence more
and more samples. This is probably best illustrated by the
Exome Aggregation Consortium database [54], which provides
detailed information on 7.4 million high-quality variants in the
exomes of 60,706 unrelated individuals. Indeed, 54% of the
observed variants are singletons and an impressive 72% are not
even observed in 1KG. This highlights that there will be enor-
mous value for medical genetics in creating pan-genomic re-
sources to aggregate common and rare variants for imputation
and association testing of commonly segregating variants on
the one hand, and the (functional) interpretation of rare vari-
ants in personal genome sequences on the other.
To the extent that common variants play an important role
for certain traits, they are likely to be present in 1KG and can
therefore in principle be imputed well and thus tested for asso-
ciation. This is, however, not the case for rare variants, which
are poorly represented by 1KG, and challenging to impute from
a microarray chip. We therefore see potential value in
4 | Marschall et al.
 at UniversitÃ  di Pisa on October 24, 2016
http://bib.oxfordjournals.org/
Downloaded from 
sequencing larger samples for diseases where common variants
appear to contribute only modestly, as illustrated by the recent
GWAS for amyotrophic lateral sclerosis [58]. Ultimately, the key
trade-off in the ‘optimal’ study design is the likelihood of find-
ing novel discoveries (power) and the associated cost (effi-
ciency). With sequencing still being a significant cost driver,
there is no simple recommendation for diverse diseases.
In addition to the discovery of novel associations, we should
also expect an increasing focus on the fine-mapping of the ini-
tial GWAS hits, that is, the localization of the causal variants
driving the association signals. Identifying these variants (and
their functional impact) is a key step in elucidating the biolo-
gical mechanisms involved. Combining genome-wide variants
with comprehensive functional annotations—for example, from
epigenomic or gene expression data sets—should be considered
a priority. We expect pan-genome data structures that are cap-
able of handling such annotations to significantly contribute to
this endeavor.
In parallel, we should expect substantial improvements in
the characterization of parts of the genome that are currently
not easily accessible with current sequencing technologies
(including repetitive regions, or those of low complexity), and
the detection of complex SVs, as these are still more challeng-
ing to call from raw sequence data. Despite efforts to capture
structural variation based on discordant mapping of short
reads, a major fraction remains undetected in large part be-
cause of their complexity and owing to the incompleteness of
the current reference genome [59, 60]. Incorporating fully
resolved high-quality structural variation data into a pan-
genomic reference, preferably from long-read sequencing data,
would greatly improve the genotyping of known SVs and limit
false-positives among novel variants. This will be highly rele-
vant in the clinical setting, where genome sequencing is ex-
pected to replace array-based copy number variation profiling
within a few years.
Cancer
Cancer is caused mostly by somatic DNA alterations that accu-
mulate during an individual’s lifetime [61]. Somatic mutations
in different individuals arise independently, and recent large
cancer studies have uncovered extensive ‘inter-patient hetero-
geneity’ among somatic mutations, with any two tumors pre-
senting a different complement of hundreds to tens of
thousands of somatic mutations [62, 63]. Heterogeneity also
manifests ‘intra-patient’, with different populations of cells pre-
senting different complements of mutations in the same tumor
[64, 65].
Inter-patient and intra-patient heterogeneity pose several
challenges to the detection and the interpretation of somatic
mutations in cancer. The availability of a pan-genome reference
would greatly improve the detection of somatic mutations in
general, through improved quality of read mapping to poly-
morphic regions, and in particular in cases when matched nor-
mal tissue is not available or when only a reduced sequence
coverage can be obtained.
In addition to a pan-genome reference, a somatic cancer
pan-genome, representing the variability in the observed as
well as inferred background alteration rate across the genome
and for different cohorts of cancer patients, would enhance the
identification of genomic alterations related to the disease
(‘driver events’) based on their recurrence across individuals.
Even more important would be the availability of a somatic
pan-genome describing the general somatic variability in the
human population, which would provide an accurate baseline
for assessing the impact of somatic alterations.
For the medium- and long-term future, we envision a com-
prehensive cancer pan-genome to be built for each tumor pa-
tient, comprising single-cell data, haplotype information as well
as sequencing data from circulating tumor cells and DNA. Such
a pan-genome will most likely constitute a much better basis
for therapy decisions compared with current cancer genomes,
which mainly represent the most abundant cell type.
Phylogenomics
Phylogenomics reconstructs the evolutionary history of a group
of species by using their complete genome sequences, and can
exploit various signals such as sequence or gene content
[66, 67]. Computational pan-genomics will allow genomic fea-
tures with an evolutionary signal to be rapidly extracted, such
as gene content tables, sequence alignments of shared marker
genes, genome-wide SNPs or internal transcribed spacer se-
quences, depending on the level of relatedness of the included
organisms. This will facilitate evolutionary analyses ranging
from the reconstruction of species phylogenies, where hetero-
geneity between genomes is high [68], to tracing epidemic out-
breaks and cancer lineages within a patient, where
heterogeneity between genomes is low. For example, the yeast
data set described in [69] allowed a phylogenetic classification
based on the presence and location of mobile elements in sev-
eral strains of S. cerevisiae. Computational pan-genomics would
also enhance such analyses when the pan-genome is built from
a set of distinct strains of the same species.
Unambiguous phylogenomic trees of organismal or cellular
lineages form invaluable input data for applications in various
biomedical fields, for example to map the evolutionary dy-
namics of mutation patterns in genomes [70] or to understand
the transfer of antibiotic resistance plasmids [71]. At the same
time, the size of the pan-genome often hampers the inference
of such a ‘tree of life’ computationally as well as conceptually.
One clear bonus offered by the pan-genome, is that for trad-
itional phylogenomics only the best aligned, and most well-
behaved residues of a multiple sequence alignment (MSA) can
be retained. In contrast, the pan-genomic representation of
multiple genomes allows for a clear encoding of the various
genomic mutations in a model of the evolutionary events. This
leads to the possibility for radical new evolutionary discoveries
in fields including the origin of complex life [72], the origin of
animals [73] and plants [74] or the spread of pathogens [75, 76],
but also inferring the relationships between cancer lineages
within a single patient [77, 78].
Impact of sequencing technology
on pan-genomics
Next-generation short-read sequencing has contributed tre-
mendously to the increase in the known number of genetic vari-
ations in genomes of many species. The inherent limitations of
commonly used short-read sequencing are 3-fold. First, the
short read lengths prohibit the interrogation of genomic regions
consisting of repetitive stretches, the direct phasing of genetic
variants [79] and the detection of large structural variations [60].
Second, nonrandom errors hamper the detection of genetic
variations [80]. Third, there is a nonuniform distribution of
sequencing coverage [81] owing to various factors including
biases in polymerase chain reaction amplification, polymerase
processivity and bridge amplification.
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Establishing pan-genome sequences ideally requires a com-
plete set of ‘phased’—that is, haplotype resolved—genetic vari-
ations. Experimental techniques to capture such linkage
information have witnessed significant progress recently, as re-
viewed by [82]. Ultimately, specialized protocols for haplotype-
resolved sequencing will be rendered obsolete once sufficiently
long sequencing reads are routinely available.
The most promising developments in sequencing technology
involve single-molecule real-time sequencing of native DNA
strands. Currently, single-molecule real-time (SMRT) sequencing
(Pacific Biosciences) is widely used for variation discovery and
genome assembly [60]. The MinION device (Oxford Nanopore
Technologies) [83] provides even longer reads of single DNA mol-
ecules, but has been reported to exhibit GC biases [84]. Data gen-
erated on the MinION platform have been successfully used for
assembly of small genomes and for unraveling the structure of
complex genomic regions [85, 86].
Despite this progress, sequencing reads are not yet suffi-
ciently long to traverse and assemble all repeat structures and
other complementary technologies are necessary to investigate
large, more complex variation. Presently, array comparative
genomic hybridization (arrayCGH), synthetic long reads
(Moleculo [87], 10X Genomics [88]), chromatin interaction meas-
urements [89] and high-throughput optical mapping [90–92] all
aid the detection of structural variation.
Beyond interrogating genomes, sequencing technologies
also serve to measure various other signals that can be seen as
additional layers of information to be stored and analyzed in a
pan-genome framework. Most notably, specialized protocols
exist to measure transcriptomes, DNA–protein interaction, 3D
genome structure, epigenetic information or translation activ-
ity. In all these cases, a current challenge consists in transition-
ing from bulk to single-cell sequencing.
We expect that novel technologies will continue to greatly
improve all mentioned applications in genomics and beyond.
Nonetheless, further decreasing costs and conducting appropri-
ate benchmark studies that illustrate specificity and sensitivity
are problems yet to be tackled.
Data structures
Besides novel experimental protocols and sequencing technolo-
gies, advances in ‘data structures’ play a key role for making
pan-genome analyses a reality. In this section, we identify im-
portant design goals for pan-genome data structures and survey
existing approaches.
First, we ground our discussion with a practical example of a
pan-genome data structure. Figure 1 presents a splicing graph
[16] for a single human gene. This compact representation of a
collection of transcripts of a given gene has seen application in
re-sequencing-based analyses, where it is used to support the
alignment of RNA sequencing reads to the entire transcriptome
[94]. It comprises genomic sequences, observed linkages be-
tween them and the original transcripts and reference genome
used to build the graph. On the one hand, this example illus-
trates that ‘computational pan-genomics’ applies to collections
of genetic sequences that are not necessarily whole genomes: to
best support the intended application of analyzing RNA
sequencing data, we here restrict our pan-genome data struc-
ture to transcribed sequences. On the other hand, this example
highlights the importance of ‘graphs’ for pan-genomic data
structures. Here, the graph consists of sequences (nodes), of
adjacencies between them (edges) and of the sequences that
gave rise to it (paths). A wide array of pan-genomic operations
relies on the interplay between these basic elements.
Design goals
Different applications give rise to different requirements for
data structures that represent pan-genomes. Figure 2 presents a
schematic overview. Depending on the specific application, a
pan-genome data structure may need to offer any of the follow-
ing capabilities.
Construction and maintenance
Pan-genomes should be constructable from different independ-
ent sources, such as (1) existing linear reference genomes and
their variants, (2) haplotype reference panels and (3) raw reads,
either from bulk sequencing of complex mixtures or from mul-
tiple samples sequenced separately (see Figure 2, ‘Construct’
operation). The data structure should allow dynamic updates of
stored information without rebuilding the entire data structure,
including local modifications such as adding a new genetic vari-
ant, insertions of new genomes and deletion of contained gen-
omes (see Figure 2, ‘Update’ operation).
Coordinate system
A pan-genome defines the space in which (pan-)genomic ana-
lyses take place. It should provide a ‘coordinate system’ to un-
ambiguously identify genetic loci and (potentially nested)
genetic variants. Desirable properties of such a ‘coordinate sys-
tem’ include that nearby positions should have similar coordin-
ates, paths representing genomes should correspond to
Figure 1. A sequence graph assembled from the Homo sapiens reference genome and all transcripts of the EEF1A1 gene in Ensembl v80 [93]. Each node represents a se-
quence found in the reference genome or transcripts, edges (black solid lines) indicate adjacencies that have been observed in transcripts and colored horizontal bars
correspond to paths of known transcripts (annotated with their Ensembl transcript ID), where each dotted line indicates that a node in the graph is part of this tran-
script. The path annotated with coordinates (6:73515750–73523797) corresponds to the reference genome.
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monotonic sequences of coordinates where possible and coord-
inates should be concise and interpretable.
Biological features and computational layers
Annotation of biological features should be coherently provided
across all individual genomes (see Figure 2, ‘Annotate’ oper-
ation). Computationally, these features represent additional
layers on top of pan-genomes. This includes information about
(1) genes, introns, transcription factor binding sites; (2)
epigenetic properties; (3) linkages, including haplotypes; (4)
gene regulation; (5) transcriptional units; (6) genomic 3D struc-
ture; and (7) taxonomy among individuals.
Data retrieval
A pan-genome data structure should provide positional access to
individual genome sequences, access to all variants and to the
corresponding allele frequencies (see Figure 2, ‘Retrieve’
Figure 2. Illustration of operations to be supported by a pan-genome data structure.
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operation). Haplotypes should be reconstructable including infor-
mation about allmaximal blocks and LDbetween two variants.
Searching within pan-genomes
Comparisons of short and long sequences (e.g. reads) with the
pan-genome ideally results in the corresponding location and
the best matching individual genome(s) (see Figure 2, ‘Map’ op-
eration). This scenario may occur for transcriptomic data as
well as for DNA re-sequencing data, facilitating the identifica-
tion of known variants in new samples (see Figure 2, ‘Variant
calling’ operation).
Comparison among pan-genomes
Given any pair of genomes within a pan-genome, we expect a
data structure to highlight differences, variable and conserved
regions, as well as common syntenic regions. Beyond that, a
global comparison of two (or more) pan-genomes, e.g. with re-
spect to gene content or population differentiation, should be
supported (see Figure 2, ‘Compare’ operation).
Simulation
A pan-genome data structure should support the generation
(sampling) of individual genomes similar to the genomes it con-
tains (see Figure 2, ‘Simulate’ operation).
Visualization
All information within a data structure should be easily access-
ible for human eyes by visualization support on different scales
(see Figure 2, ‘Visualize’ operation). This includes visualization
of global genome structure, SVs on genome level and local vari-
ants on nucleotide level, but also biological features and other
computational layers (see the ‘Biological features and computa-
tional layers’ section) should be represented.
Efficiency
We expect a data structure to use as little space on disk and
memory as possible, while being compatible to computational
tools with a low running time. Supporting specialized hardware,
such as general purpose graphics processing units or field-
programmable gate arrays, is partly an implementation detail.
Yet, in some cases, the target platform can influence data struc-
ture design significantly.
Approaches
There are natural trade-offs between some of the desiderata
discussed in the previous section. For instance, the capability to
allow dynamic updates might be difficult to achieve while using
only small space and allowing for efficient indexing. It is one of
the core challenges of computational pan-genomics to design
data structures that support (some of) the above query types ef-
ficiently. While desirable in principle, we consider it difficult, if
not impossible, to develop a solution that meets ‘all’ the listed
requirements at once. Therefore, future research should aim to
delineate the compromises that may have to be made and
thereby provide guidance on which solution is suitable for
which application scenario. As the field matures, additional
queries will appear, and data structures will need to adapt to
support them.
In the following, we discuss traditional approaches to meet
fundamental requirements for genome analysis, first exten-
sions for pan-genomes, as well as future challenges.
Unaligned sets of sequences
The conceptually simplest representation of a pan-genome con-
sists of a set of individual sequences (Figure 3A), which might
be either whole genomes or parts of it. The traditional view of a
species’ pan-genome as the set of all genes [14], which is preva-
lent in microbiology, can be considered an example for this.
Unaligned whole genome sequences on the other hand are, in
general, of limited utility for most applications, especially when
the genomes are long. So we consider collections of individual
genomes mostly as input to build the more advanced represen-
tations discussed in the following.
MSA-based representations
Pan-genomes can be represented by alignments of multiple
genomes. In an MSA, the input sequences are aligned by insert-
ing gap characters into each sequence (Figure 3B). The result is
a matrix, where each column represents putatively homolo-
gous characters. Refer to [95, 96] for reviews on current meth-
ods and remaining challenges. Such classical colinear
alignments are not able to capture larger rearrangements like
inversions and translocations well and hence only apply to
short genomic regions such as single genes or to similar
genomes.
One advantage of using an MSA as a representation of a
pan-genome is that it immediately defines a coordinate system
across genomes: a column in the alignment represents a loca-
tion in the pan-genome. MSAs furthermore support many com-
parison tasks.
All approaches designed for linear reference genomes can,
in principle, be extended to multiple alignments at the expense
of adding bookkeeping data structures to record where the gaps
are. Efficient data structures for prefix sum, rank and select
queries exist [97], which can be used for doing projections to
and from a sequence and its gapped version as a row of an MSA.
MSAs can be compactly represented by journaled string trees
[98]. This data structure also allows for efficiently executing se-
quential algorithms on all genomes in the MSA simultaneously.
One example for such a sequential algorithm is online pattern
matching, that is, searching all genomes for the exact or ap-
proximate occurrence of a pattern without building an index
structure first.
When aligning two or more whole genomes, structural dif-
ferences such as inversions and translocations need to be
taken into account. Standard methods for a colinear MSA are
therefore not applicable. Instead, one aims to partition the in-
put genomes into blocks such that sequences within blocks
can be aligned colinearly. Creating such a partitioning is a
nontrivial task in itself and mostly approached through graph
data structures that represent local sequence similarities and
adjacencies. On the one hand, such graphs therefore facilitate
whole genome alignment. On the other hand, they can be
understood as representations of the pan-genome. Concrete
realizations of this idea include A-Bruijn graphs [99], Enredo
graphs [100] and Cactus graphs [101, 102]. For detailed defin-
itions and a comparison of these concepts, we refer the reader
to the review [103].
Block-based MSAs can also serve as the basis for a coordin-
ate system on a pan-genome: by numbering blocks as well as
numbering columns inside each colinearly aligned block, a no-
tion of a position in a pan-genome can be defined. This idea is
explored by Herbig et al. [104], who furthermore show how it can
serve as a foundation for visualization.
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k-mer-based approaches
Starting from assembled genomes, contigs or just collections of
(error-corrected) reads, a pan-genome can also be represented
as a collection of k-mers, i.e. strings of length k. The task of effi-
ciently counting all k-mers occurring in an input sequence has
been studied extensively in recent years and many solutions
are available, including Jellyfish [105], DSK [106] and KMC2 [107].
Such a k-mer collection is a representation of the corresponding
de Bruijn Graph (DBG), illustrated in Figure 3C. DBGs were intro-
duced in the context of sequence assembly [108], but can be
Figure 3. Selected examples of pan-genome representations: (A) three unaligned sequences, colors highlight similarities; (B) a MSA of the same three sequences; (C) the
DBG of the first (red) sequence block; (D) acyclic sequence graph, paths representing the three haplotypes shown as solid/dashed/dotted lines; (E) cylic sequence graph;
(F) Li–Stephens model of the first nine characters with states indicated by circles, emission distributions given in boxes and transitions given by arrows; dashed arrows
indicate the (less likely) ‘recombination’ transitions.
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used as pan-genome representations supporting many applica-
tions beyond assembly. When k-mer neighborhood queries are
sufficient, and no k-mer membership queries are required, then
even more space-efficient data structures for DBGs exist [109].
When building DBGs for multiple input samples, one can
augment each k-mer by the set of samples containing it. This
idea is realized in colored DBGs where we color each k-mer ac-
cording to the input samples it occurs in. Colored DBGs have
been used successfully for reference-free variant calling and
genotyping [110]. Recently, Holley et al. [111] introduced Bloom
filter tries, a data structure able to efficiently encode such col-
ored DBGs.
For k-mer-based representations of pan-genomes, the length
k is obviously an important parameter, and picking the right
value depends on the intended application. Data structures able
to represent a pan-genome at different granularities (i.e. at dif-
ferent values of k) are hence an interesting research topic. For
instance, Minkin et al. [112] show that iteratively increasing k
helps to capture nested synteny structure.
Pan-genomes encompassing many species can be encoded
as a mapping between k-mers and clades: given a phylogenetic
tree, each k-mer is mapped to the lowest common ancestor
of all genomes containing it. This technique was introduced
by Wood and Salzberg [113], who show that it efficiently sup-
ports the task of analyzing the composition of metagenomic
samples.
Advantages of k-mer-based representations include simpli-
city, speed and robustness: it is not necessary to produce an as-
sembly or an alignment, which both can be error-prone, and
efficient Bloom-filter-based data structures to store them exist
and are available in mature software libraries such as the GATB
[114]. However, they do not explicitly represent structural infor-
mation at distances greater than the k-mer length. For applica-
tions where such information is needed, DBGs can sometimes
serve as a basis to design richer data structures. Colored DBGs
[110, 111] are an example of this because they store information
about occurrence in individual genomes on top of each k-mer.
Further sequence graphs
Building on the above ideas, more general approaches concep-
tualize a pan-genome as a (edge- or node-labeled) graph of gen-
eric pieces of sequence. Such graphs are not necessarily
constructed using an MSA and the constituting sequences are
not necessarily fixed-length k-mers. Figure 3D and E show ex-
amples of an acyclic and a cyclic sequence graph, respectively.
Individual genomes can be represented as paths in such graphs
and node identifiers can serve as a ‘coordinate system’.
Compressed DBGs (also called compacted DBGs), which col-
lapse chains of non-branching nodes in a DBG into a single
node, are an example of this. Marcus et al. [115] show how such
compressed DBGs can be constructed for a pan-genome by first
identifying maximal exact matches using a suffix tree, bypass-
ing uncompressed DBGs. Beller and Ohlebusch [116] and Baier
et al. [117] show how the same can be achieved more efficiently,
using an FM index resp. compressed suffix trees and the
Burrows–Wheeler transform. Trading efficiency for comprehen-
sibility, compressed DBGs can also form the foundation for
annotated pan-genomes stored in graph databases [118].
Useful data structures for pan-genomes may combine some
of the basic approaches discussed so far. For example, PanCake
[119] uses a graph-based structure to represent common gen-
omic segments and uses a compressed multiple-alignment-
based representation in each node of the graph. Dilthey et al.
[15] propose a generative model by representing sequence vari-
ation in a k-mer-emitting hidden Markov model (HMM).
Further examples of implementations of sequence graphs
include the Global Alliance for Genomics and Health (GA4GH)
‘side graph’ data model and the FASTG format (http://fastg.sour
ceforge.net). Side graphs represent a pan-genome as a set of se-
quences and an additional set of joins, each of which defines an
extra adjacency between the sides of two bases within the se-
quences. The GA4GH graph tools (https://github.com/ga4gh/ser
ver and https://github.com/ga4gh/schemas) allow side graphs
and embeddings of individual sampled genomes in that graph
to be made available over the Internet, for data distribution and
remote analysis.
Haplotype-centric models
When a fixed set of (non-nested) sequence variants is con-
sidered, every haplotype in a population can be represented as
a string of fixed length. The character at position k reflects the
status of the k-th variant. When all variants are bi-allelic, then
these haplotype strings are formed over a binary alphabet. Such
collections of haplotypes are often referred to as ‘haplotype
panels’. This representation is favorable for many population
genetic analyses because it makes shared blocks of haplotypes
more easily accessible, for instance compared with sets of paths
in a graph.
A recent data structure to represent haplotype panels,
termed Positional Burrows–Wheeler Transform (PBWT) [120], fa-
cilitates compression and supports the enumeration of max-
imal haplotype matches.
One of the most widely used haplotype-based models is the
Li–Stephens model [121]. In a nutshell, it can be viewed as a
HMM with a grid of states with one row per haplotype and one
column per variant, as sketched in Figure 3F. Transitions are de-
signed in a way such that staying on the same haplotype is
likely but jumping to another one is also possible. It hence is a
generative probabilistic model for haplotypes that allows for
sampling new individuals and provides conditional probabil-
ities for new haplotypes given the haplotypes contained in the
model.
Computational challenges
Pan-genomic data have all of the standard properties of ‘Big
Data’—in particular, volume, variety, velocity and veracity.
Especially owing to the sheer size of generated sequencing data,
extreme heterogeneity of data and complex interaction on differ-
ent levels, pan-genomics comes with big challenges for algorithm
and software development [122]. The International Cancer
GenomeConsortiumhas amassed a data set in excess of twopeta-
bytes in just 5 years with the conclusion to store data generally in
clouds, providing an elastic, dynamic and parallel way of process-
ing data in a cheap, flexible, reliable and securemanner [123].
Currently large computing infrastructure providers and large
public repositories (e.g. National Center for Biotechnology
Information (NCBI)/European Bioinformatics Institute (EBI)/DNA
Data Bank of Japan (DDBJ)) are completely separated. We need
hybrids that offer both large public repositories as well as the
computing power to analyze these in the context of individual
samples/data. We consider it desirable to bring the computation
as close as possible to the data by uploading queries or in-
database computing.
‘Distributed and parallel computing’ will be necessary to suc-
cessfully handle pan-genome data in practice. To this end, lever-
aging the capabilities of existing Big-Data frameworks is
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desirable and should be combinedwith bringing the computation
as close as possible to the data. On the practical side, tackling
these challenges will also involve establishing widely accepted
standards for ‘file formats’ for sequence graphs and related data
like read alignments to such graphs. On the theoretical side,
studying changes in algorithmic complexity when working with
sequence graphs instead of sequences will be an interesting and
challenging aspect of computational pan-genomics.
All these general challenges apply to all individual computa-
tional problems we discuss in the following.
Read mapping
Given a set of reads sequenced from a donor, ‘read mapping’
consists in identifying parts of the reference genome matching
each read. Read mapping to a pan-genome has a potential to
improve alignment accuracy and subsequent variant calling, es-
pecially in genomic regions with a high density of (complex)
variants.
For a single reference sequence, the read mapping problem
has mostly been solved by indexing the reference into a data
structure that supports efficient pattern search queries. Most
successful approaches use k-mer-based or Burrows–Wheeler-
transform-based indexes, as reviewed in [124]. Indexing a pan-
genome is more complicated.
Efficient indexing of a set of reference genomes for read
mapping was first studied in [125, 126]. The approach uses com-
pressed data structures, exploiting the redundancy of long runs
of the same letter in the Burrows–Wheeler transform of a collec-
tion of similar genomes. This approach yields a reasonably
compressed representation of the pan-genome, but read align-
ment efficiency is hampered by the fact that most reads map to
all of the references, and that extraction of these occurrence lo-
cations from a compressed index is potentially slow. More re-
cently, approaches based on Lempel–Ziv compression have
been proposed to speed-up the reporting of occurrences, as re-
viewed in [127].
The earliest approach to index a ‘sequence graph’ (see the
‘Approaches’ section) was proposed in [128], where k-mer
indexing on the paths of such a graph was used; instead of a full
sequence graph, a ‘core’ sequence graph was used where col-
umns were merged in regions of high similarity (core genome)
to avoid extensive branching in the graph. After finding seed oc-
currences for a read in this graph, the alignment was refined lo-
cally using dynamic programming. Similar k-mer indexing on
sequence graphs has since been used and extended in several
read mapping tools such as MuGI [129], BGREAT [130] and VG
(https://github.com/ekg/vg).
Instead of k-mer indexing, one can also use Burrows–
Wheeler-based approaches, based on appending extracted con-
texts around variations to the reference genome [131]. Context
extraction approaches work only on limited pattern length, as
with long patterns they suffer from a combinatorial explosion
in regions with many variants; the same can happen with a full
sequence graph when all nearby k-mer hit combinations are
checked using dynamic programming. There is also a special
Burrows–Wheeler transform and an index based on that for a
sequence graph [132, 133]. This approach works on any pattern
length, but the index itself can be of exponential size in the
worst case; best case and average case bounds are similar to the
run-length compressed indexes for sets of references like [126].
The approach is also likely to work without exponential growth
on a core sequence graph of [128], but as far as we know, this
combination has not been explored in practice. A recent
implementation (https://github.com/jltsiren/gcsa2) avoids the
worst case exponential behavior by stopping the construction
early; if this happens, the approach also limits the maximum
read length. This implementation has been integrated into VG
as an alternative indexing approach. HISAT2 (https://ccb.jhu.
edu/software/hisat2/index.shtml) [94] implements an index
structure that is also based on [132], but builds many small
index structures that together cover the whole genome.
In summary, a number of approaches to perform read map-
ping against a pan-genome reference under various representa-
tion models exist, and efficient implementations for daily usage
are under active development. However, we consider this field
as being far from saturated and still expect considerable pro-
gress in both algorithmic and software engineering aspects. To
reach the full potential of these developments, the interactions
between read mapping and variant calling methods need to be
considered.
Variant calling and genotyping
The task of determining the differences between a sequenced
donor genome and a given (linear) reference genome is com-
monly referred to as ‘variant calling’. In case of diploid or poly-
ploid organisms, we additionally want to determine the
corresponding ‘genotype’. In the face of pan-genome data struc-
tures, variant calling decomposes into two steps: identifying
‘known’ variants already represented in the data structure and
calling ‘novel’ variants. Refer to Schneeberger et al. [128] for an
early work on pan-genome variant calling. They do not only
show the feasibility of short read alignment against a graph rep-
resenting a pan-genome reference (see the ‘Read mapping’ sec-
tion) but also demonstrate its positive impact on variation
calling in the frame of the Arabidopsis 1001 Genomes Project.
Known variants
By using a pan-genome reference, one merges read mapping
and calling of known variants into a single step. Read align-
ments to sequence variants encapsulated in our pan-genome
data structure indicate the presence of these variants in the
donor genome. In particular, this applies not only to small vari-
ants which can be covered by a single read (such as SNPs and
indels), but also to larger SVs such as inversions or large dele-
tions. Integrating those steps potentially decreases overall pro-
cessing time and, more importantly, removes read-mapping
biases toward the reference allele and hence improves accuracy
of calling known variants. One important challenge is to statis-
tically control read mapping ambiguity on a pan-genome data
structure. Leveraging the associated statistical models for esti-
mating genotype likelihoods is expected to lead to significant
improvements in genotyping.
As a first major step in that direction, Dilthey et al. [15] cast
the (diploid) variant calling problem into finding a pair of paths
through a pan-genome reference represented as a k-mer-
emitting HMM. They demonstrate that this leads to substan-
tially improved performance in the variation-rich MHC region.
Novel variants
Detecting variants not present in a pan-genome data structure
is similar to traditional variant calling with respect to a linear
reference genome. Still, differences exist that require special at-
tention. The most straightforward way to use established vari-
ant calling methods is to use read alignments to a pan-genome
and project them onto a linear sequence. For small variants
such as SNPs and indels, that are contained within a read, this
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approach is likely to be successful. Methods to characterize
larger structural variation (SV) need to be significantly updated.
SV calling methods are usually classified into four categories
based on the used signal: read pair, read depth, split read and
assembly, as reviewed by Alkan et al. [59]. Each of these para-
digms has its merits and shortcomings, and state-of-the-art
approaches usually combine multiple techniques [134]. Each of
these ideas can and should be translated into the realm of pan-
genomes. For split-read- and assembly-based approaches, the
problem of aligning reads and contigs, respectively, to a pan-
genome data structure (while allowing alignments to cross SV
breakpoints) needs to be addressed. In case of read pair meth-
ods, a different notion of ‘distance’ is implied by the pan-
genome model and has to be taken into account. For read depth
methods, statistical models of read mapping uncertainty on
pan-genomes have to be combined with models for coverage
(biases). Developing standards for reporting and exchanging
sets of potentially nested variant calls is of great importance.
Somatic mutations
Calling somatic mutations from paired tumor/normal samples
is an important step in molecular oncology studies. Refer to the
‘Cancer’ section for details and to [135] for a comparison of cur-
rent work flows. Calling somatic variants is significantly more
difficult compared with calling germ-line variants, mostly
owing to tumor heterogeneity, the prevalence of SVs and the
fact that most somatic variants will be novel. Pan-genome data
structures promise to be extremely useful in cancer studies for
the stable detection of somatic variants. A conceivable ap-
proach for leveraging pan-genome data structures in this con-
text would be to map reads from the matched normal sample to
the pan-reference, call germ-line mutations, create a restricted
pan-genome with detected variants and map tumor reads to
that pan-reference for calling somatic mutations. There are
many more potential applications including building a pan-
genome representation of a heterogeneous tumor to be used as
a starting point for retracing tumor evolution.
Storing variants
Storing and exchanging variant calls genotyped in a large cohort
of samples increasingly becomes a bottleneck with growing co-
hort sizes. Some improvement is achieved by adopting binary
instead of text-based data formats for variant calls, i.e. using
BCF instead of VCF (http://samtools.github.io/hts-specs/), but
more efficient approaches are urgently needed. Organizing data
by individual rather than by variant while sorting variants by al-
lele frequency has proven beneficial for compression and some
retrieval tasks [136]. We expect the question of storing, querying
and exchanging variant data to remain an active and relevant
field of research in the coming years.
Haplotype phasing
Humans are diploid, that is, each chromosome comes in two cop-
ies, one inherited from the mother and one inherited from the
father. The individual sequences of these two chromosomal cop-
ies are referred to as ‘haplotypes’, where one often restricts the
attention to polymorphic sites. The process of assigning each al-
lele at heterozygous loci to one of the two haplotypes is referred
to as ‘phasing’. Plants are often polyploid. For example, wheat
can be tetra- (¼ 4 copies) or hexaploid (¼ 6 copies), while certain
strawberries are even decaploid (¼ 10 copies). As an extreme, the
‘ploidy’ of viral quasispecies, that is, the number of different viral
strains that populate an infected person (see the ‘Viruses’
section) is usually unknown and large. The same applies to het-
erogeneous tumors, as discussed in ‘Cancer’ section.
Pan-genome data structures have the potential to, on the
one hand, store haplotype information and, on the other hand,
be instrumental for phasing. Currently, several approaches for
obtaining haplotype information exist, as reviewed in [79, 137].
‘Statistical phasing’ [138] uses genotype information of large co-
horts to reconstruct haplotypes of all individuals based on the
assumption that haplotype blocks are conserved in a popula-
tion. Once sets of haplotypes, called reference panels, are
known, additional individuals can be phased by expressing the
new haplotypes as a mosaic of the already known ones. The
question of how to best organize and store reference panels is
open. To this end, Durbin [120] has proposed the aforemen-
tioned PBWT index structure. We consider marrying reference
panels to pan-genome data structures an important topic for fu-
ture research.
To determine haplotypes of single individuals, including
rare and de novo variants, statistical approaches are not suitable
and experimental techniques to measure linkage are needed.
Such techniques include specialized protocols and emerging
long-read sequencing platforms, as discussed in ‘Impact of
sequencing technology on pan-genomics’ section. Currently,
first approaches for haplotype-resolved local assembly are
being developed [139]. More literature exists on the problem of
phasing from aligned long reads, e.g. [140–142]. In practice, this
technique is hampered by insufficient alignment quality of long
error-prone reads. As phasing is based on heterozygous loci,
avoiding allelic biases during read mapping by means of pan-
genome data structures can contribute to solving this problem.
Combining the virtues of read-based phasing with statistical in-
formation from reference panels is an active area of research
[87]. Leveraging pan-genome data structures that encode refer-
ence haplotypes toward this goal constitutes a promising re-
search direction.
These problems are amplified when phasing organisms or
mixtures of higher or unknown ploidy such as plants, viral qua-
sispecies or tumors. Algorithms with manageable runtime on
polyploid organisms [143, 144] and for the reconstruction of
quasispecies [145, 146] require the use of specialized techniques
(especially when allele frequencies drop below sequencing error
rates). Extending these approaches to pan-genome data struc-
tures is another challenging topic for future research.
Visualization
Pan-genomics introduces new challenges for data visualization.
Fundamentally, the problems relate to how to usefully view a
large set of genomes and their homology relationships, and in-
volve questions of scale and useful presentation in the face of
huge volumes of information.
At a high level of abstraction, pan-genome bag-of-genes
approaches can be visualized using methods for comparing
sets, such as Venn diagrams, flower plots and related represen-
tations. For example, the recent tool Pan-Tetris visualizes a
gene-based pan-genome in a grid [147], color-coding additional
annotation. For divergent genomes, as in bacterial- and meta-
pan-genomics, and where complete assembly is not possible,
such approaches provide useful summary information.
For the viewing of individual, assembled genomes or se-
quences, genome browsers and applications frequently display
an individual sequence along a linear or circular axis on which
other genomics information is visualized, as reviewed in [148].
This trope, which is popular and widely understood, forces
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interpretation through the lens of one chosen genome. When
this genome is a distantly related reference genome there is a
visual reference bias, which may lead to misinterpretation.
Pan-genome displays can potentially help to alleviate this
visual bias. One option is to aim to improve linear visualiza-
tions: either the chosen individual reference sequence can be
replaced by a more visually useful imputed pan-genome refer-
ence, or the pan-genome data structures, which relate different
genomes in the population, can be used to translate informa-
tion to the most closely related genome possible for the display.
In the former case, a pan-genome display can be made more in-
clusive than any single genome [149]. At the base level such in-
clusive displays are somewhat analogous to popular MSA
displays such as Mauve [150] or Jalview [151] that focus on dis-
playing all the differences between a set of sequences as clearly
as possible. The latter case, translation, where a pan-genome
alignment is used to show information on the most closely
related genome possible, is likely to become more popular as
the number of available personal genomes grows, see [25] for an
early example of such an approach.
More adventurously than linear layouts, pan-genome dis-
plays can attempt to visualize graphs of variation. This has the
flexibility of allowing arbitrary genome variation within a clean
semantic model, but can prove visually complex for even small,
nontrivial examples. For example, a graph of a few dozen bac-
terial strains contains tens to hundreds of thousands of nodes
and edges. So far graph visualizations have proved popular for
assemblies, and the visualization of heterozygosity, for ex-
ample, DISCOVAR [152], contains a module that allows you to
visualize subsets of an assembly graph in a figure. One popular
tool is Cytoscape [153], which is a generic biological graph/net-
work visualization tool, but lacks scalability and semantic navi-
gation. Another tool, Bandage [154], visualizes de novo assembly
graphs specifically.
A number of challenges exist moving forward. In a useful
visualization it will be possible to navigate and to zoom in and
out on pan-genome structures. Zooming should be done se-
mantically, i.e. different zoom levels can use different represen-
tations of the data to convey biologically relevant information.
The upper scales should give information about global genome
structure. Zooming in the visuals should focus on SVs in a gen-
omic region and the most zoomed in views should enable ex-
ploration of local variants on nucleotide level. Furthermore,
these visuals need to be put in the context of the phylogeny, e.g.
the relation of the various samples that went into the pan-
genome. This will enable rapid identification and interpretation
of observed variants. Finally, any pan-genome graph visualiza-
tion should offer the same basic features that current reference-
based genome browsers have. There should be visual ways to
indicate biologically interesting features such as gene annota-
tions and position-based continuous valued signals such as
wiggle tracks in the University of California Santa Cruz (UCSC)
genome browser. Basic analytical capabilities would be benefi-
cial to visually highlight interesting biologically relevant muta-
tions. For example, it would be useful to have different visual
representations for different types of mutations: indels, (non)-
synonymous SNPs, SVs, repeats, etc.
Data uncertainty propagation
One of the computational (and modeling) challenges facing the
field of pan-genomics is how to deal with data uncertainty
propagation through the individual steps of analysis pipelines.
To do so, the individual processing steps need to be able to take
uncertain data as input and to provide a ‘level of confidence’ for
the output made. This can, for instance, be done in the form of
posterior probabilities. Examples where this is already common
practice include read mapping qualities [155] and genotype like-
lihoods [156].
Computing a reasonable confidence level commonly relies on
weighing alternative explanations for the observed data. In the
case of read mapping, for example, having an extensive list of al-
ternative mapping locations aids in estimating the probability of
the alignment being correct. A pan-genome expands the space of
possible explanations and can, therefore, facilitate the construc-
tion of fairer andmore informative confidence levels.
As an illustration, consider a pipeline including readmapping,
variant calling and genotyping, phasing and association testing.
Substantial uncertainty and sequence composition biases are al-
ready inherent to the input data generated by next-generation
sequencing [157]. The following read alignment step adds ambi-
guity in read placement, leading to uncertain coverage and frag-
ment lengths. As a result, this leads to uncertainties in variant
calling, genotyping and phasing. This, finally, results in uncer-
tainties in association testing in GWAS. The precise quantifica-
tion of the propagation of these effects is largely unclear. The
advent of ever larger and refined panels, supported by appropri-
ate pan-genome data structures, bears the promise of making
quantification and alleviation of such effects possible.
Conclusions
Already today, the DNA having been sequenced for many bio-
logically coherent ensembles—such as certain taxonomic units
or virus populations—likely captures the majority of their fre-
quently occurring genetic variation. Still, the pace at which gen-
omes are currently sequenced is on a steep rise, thanks to
accumulation of sequencers in laboratories and frequent, sig-
nificant advances in sequencing technology. Therefore, captur-
ing ‘all of genomes’, in terms of genetic variation content and
abundance, is no longer wishful thinking, but will materialize
soon for many species, populations and cancer genomes. In
other words, life sciences have entered the era of ‘pan-
genomics’, which is characterized by knowing ‘all’ major genetic
variation of a collection of genomes of interest. In this article,
we addressed the question of how to arrange and analyze this
incredible wealth of knowledge and also how to deal with some
of the consequences in downstream analyses.
Present status
The computational aspects that need to be considered fan out
across a large variety of particular challenges, usually governed
by the realm of application they stem from. We have listed the
many facets of pan-genomes in terms of functionality, annota-
tional detail, computational efficiency issues and visualization.
We have discussed how the availability of well-arranged pan-
genomes will affect population genetics, cancer genomics,
pathogen research, plant breeding, phylogenomics, functional
genomics as well as genetic disease research and GWAS. We
have surveyed the impact of sequencing technology advances
on the field of pan-genomics, and we have considered also the
complications that come along with these advances. We have
put particular emphasis on data structures and supporting algo-
rithms that make it possible to consistently work with
pan-genomes. One of the currently most evident processes in
computational pan-genome research is the move away from
linear reference genomes toward reference systems that are
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rooted in graph theory in some form. The effort of the Data
Working Group of the GA4GH is a prominent example for this.
We have also discussed how the transition in terms of data
structures will affect operations such as read mapping, variant
discovery, genotyping and phasing, all of which are at the core
of modern genomics research. Last but not least, we have ana-
lyzed the issues that arise in visualizing pan-genomes, and we
have briefly discussed future issues in uncertain data handling,
recently an ever recurring theme in genome data analysis, often
arising from the repetitive structure of many genomes.
We have concentrated on computational challenges of pan-
genomics in this survey. We are aware that there are also polit-
ical challenges that have to be addressed that concern data
sharing and privacy. Clearly, the usefulness of any pan-genomic
representation will increase with the number of genomes it rep-
resents, strengthening its expressive and statistical power.
Unfortunately, however, only a fraction of the sequenced data
is currently publicly available. This is partly owing to the confi-
dential nature of human genetic data, but also, to a large extent,
by missing policies and incentives to make genomic data open
access or to prevent intentional withholding of data. Funding
agencies like the National Institutes of Health in the USA have
started to address these issues [158] (see also http://www.nih.
gov/news-events/news-releases/nih-issues-finalized-policy-gen
omic-data-sharing).
Future directions
Overall, we have provided a broad overview of computational
pan-genomics issues, which we hope will serve as a reference for
future research proposals and projects. However, so far, we have
mostly been addressing how to deal with genomes as sequences,
that is, from a ‘one-dimensional’ point of view, and so we have
been focusing on storing and analyzing sequences and the mu-
tual relations of particular subsequence patches, like variant al-
leles and their interlinkage, genes and/or transcriptomes. We
have done this because we believe that at this point in genomics
history, only the consistent exploration and annotation of ex-
haustive amounts of sequence information can lay the solid
foundation for additional ‘pan-genomics oriented’ steps.
Yet, even after having resolved the corresponding issues—
and we are hopeful that, at this point, our summary has helped
to consistently structure these—there is more to follow. New
approaches have already appeared on the horizon that will
benefit from the cornerstone provided by primarily sequence-
driven pan-genomics. For example, it can be expected that one
can lift pan-genomes into three dimensions in the mid-term fu-
ture, thanks to rapidly developing techonolgies that allow to
infer their three-dimensional conformation. This will mean
that future, three-dimensional pan-genomes will not only rep-
resent all sequence variation applying for species or popula-
tions, but also encode their spatial organization as well as their
mutual relationships in that respect.
Epigenomics topics have not been exhaustively addressed
here either, but will need to be addressed as soon as the first ‘pri-
mary’ pan-genomes stand. Technologies that do not only map se-
quential and three-dimensional arrangement, but also additional
biochemical modifications have likewise been on a steep rise re-
cently. Most importantly, we will be in position to link sequential
pan-genomes to maps that indicate hypo- and hypermethylated
regions relatively soon. Likely, the integration of such basic bio-
chemical modifications will serve as template for further, often
more complex elements of biochemical genomic maps.
In summary, the emergence of computational pan-
genomics as a field is a major advance in contemporary gen-
omics research. We have entered an era that holds the prom-
ise to close large gaps in global maps of genomes and to draw
the full picture of their variability. We therefore believe that
we can expect to witness amazing, encompassing insights
about extent, pace and nature of evolution in the mid-term
future.
Key Points
• Many disciplines, from human genetics and oncology
to plant breeding, microbiology and virology, com-
monly face the challenge of analyzing rapidly increas-
ing numbers of genomes.
• Simply scaling up established bioinformatics pipelines
will not be sufficient for leveraging the full potential of
such rich genomic data sets.
• Novel, qualitatively different computational methods
and paradigms are needed and we will witness the
rapid extension of computational pan-genomics, a
new sub-area of research in computational biology.
• The transition from the representation of reference
genomes as strings to representations as graphs is a
prominent example for such a computational para-
digm shift.
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